These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22489664)

  • 1. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis.
    Krell J; Frampton AE; Jacob J; Pellegrino L; Roca-Alonso L; Zeloof D; Alifrangis C; Lewis JS; Jiao LR; Stebbing J; Castellano L
    Mol Diagn Ther; 2012 Jun; 16(3):167-72. PubMed ID: 22489664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
    Sun D; Zhong J; Wei W; Chen X; Liu J; Hu Z
    J Gene Med; 2019 Apr; 21(4):e3075. PubMed ID: 30716792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.
    Petrović N; Kolaković A; Stanković A; Lukić S; Řami A; Ivković M; Mandušić V
    Cancer Biomark; 2016; 16(3):385-94. PubMed ID: 26889816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-205-5p Downregulation and
    Kalinkova L; Nikolaieva N; Smolkova B; Ciernikova S; Kajo K; Bella V; Kajabova VH; Kosnacova H; Minarik G; Fridrichova I
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
    Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.
    Rask L; Balslev E; Søkilde R; Høgdall E; Flyger H; Eriksen J; Litman T
    Cell Oncol (Dordr); 2014 Jun; 37(3):215-27. PubMed ID: 25027758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
    Qiao EQ; Yang HJ; Zhang XP
    J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
    Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
    Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-640 and MiR-525-5p as Relapse-Associated MicroRNAs in Systematically Untreated Individuals with Low-Risk Primary Breast Cancer.
    Tang HH
    Tohoku J Exp Med; 2023 Jun; 260(2):171-179. PubMed ID: 36990742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.